研究文章
评估乳腺癌的病理反应新辅助化疗后改良根治性乳房切除术标本
|
| 特征 |
肿瘤局部响应(pPR) |
肿瘤完全缓解(pCR) |
|
或(95%置信区间) |
|
| 年龄 |
|
|
|
|
| 到59岁 |
27 (73%) |
10 (27%) |
0.552 |
0.60 (0.11 - 3.26) |
| 60岁及以上 |
9 (81.8%) |
2 (18.2%) |
| 家族病史 |
|
|
|
|
| 是的 |
5 (62.5%) |
3 (37.5%) |
0.371 |
0.48 (0.09 - 2.42) |
| 没有 |
31 (77.5%) |
9 (22.5%) |
| 样本大小 |
|
|
|
|
| 到5厘米 |
26 (70.3%) |
11 (29.7%) |
0.165 |
0.23 (0.02 - 2.07) |
| 超过5厘米 |
10 (90.9%) |
1 (9.1%) |
| FNA)年级 |
|
|
|
|
| 1级 |
14 (66.7%) |
7 (33.3%) |
0.240 |
0.45 (0.12 - 1.71) |
| 2级 |
22 (81.5%) |
5 (18.5%) |
| 原位乳腺管癌 |
|
|
|
|
| 是的 |
11 (84.6%) |
2 (15.4%) |
0.348 |
2.20 (0.41 - 11.75) |
| 没有 |
25 (71.4%) |
10 (28.6%) |
| 类型的癌症 |
|
|
|
|
| 聚合酶链反应 |
1 (11.1%) |
8 (88.9%) |
< 0.001# |
- - - - - - |
| 浸润性导管癌号 |
35 (92.1%) |
3 (7.9%) |
| 浸润性小叶癌 |
0 |
1 (100%) |
| Lymphovascular入侵 |
|
|
|
|
| 是的 |
13 (100%) |
0 |
0.015# |
- - - - - - |
| 没有 |
23 (65.7%) |
12 (34.3%) |
|
|
统计学意义。
|
